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ABSTRACT 
I demonstrate that a member of the protein family A Disintegrin and 
Metalloprotease (ADAM), ADAM23, is expressed in the olfactory epithelium (OE) and 
may inhibit neural progenitor cell (NPC) proliferation. I generated a list of ten gene 
candidates and selected ADAM23 for further study, based on its conserved protein 
structure and accumulating evidence for its role in cell cycle progression of proliferative 
cells. I next determined ADAM23 protein localization using immunohistochemistry and 
measured both mRNA and protein expression post-lesion with RT-qPCR and Western 
blot.  ADAM23 is expressed in multiple cell types of the OE, including glial 
Sustentacular (Sus) cells and neurons. There are four splice variants present in the OE, 
and mRNA expression decreases three to four-fold post-lesion but recovers to pre-lesion 
levels within two weeks (p<0.05, ANOVA). ADAM23 is poised to regulate NPC 
quiescence through contact with Sus cell end-feet. It may also facilitate important 
Sus:neuron interactions.  
 
1 
  
CHAPTER ONE 
INTRODUCTION 
Regeneration in the Nervous System 
Mammals have a limited capacity for repair of their damaged tissues. We cannot 
regrow limbs or eyes like some lower vertebrate species. Furthermore, the capacity to 
regenerate decreases with age even for proliferative cells of the skin and gut, as 
demonstrated by thinning and scarring of the epithelial tissue (Rando et al, 2012). 
Nervous tissue is not as easily repaired and injuries sustained to the brain or spinal cord 
are often life-altering. Nonetheless, adult neurogenesis can and does occur in three 
primary areas of the mammalian nervous system: the olfactory epithelium (OE), the 
subventricular zone (SVZ), and the subgranular zone (SGZ) (Riddle and Lichtenwalner, 
2007). However, only the OE produces afferent excitatory projection neurons throughout 
life (Whitman and Greer, 2009). Learning more about the mechanisms within the OE that 
promote regeneration could be applied to the repair of other nervous system tissues in the 
future. 
First, it is important to consider the similarities and differences between 
neurogenesis that occurs during development as opposed to that during regeneration. 
Stem cell populations in adult tissues must remain undifferentiated and self-renew for an 
extended period of time, but not be permitted to generate new cells in an uncontrolled 
manner. They must be responsive to extracellular signals upon injury in order to generate 
multiple tissue-specific cell types as needed; and when repair is finished they must re-
2 
enter a state of quiescence.  
Stem cell maintenance and activation 
Between stem cell niches there are certain common and divergent characteristics. 
It is common for stem cells to be adherent to a basal lamina, and in close proximity to the 
vasculature such that they respond to cytokines, chemokines, and other circulating factors 
(Ovadia et al, 2013; Putnam, 2014). NPCs of the SVZ and OE are similar in this way but 
differ in origin and morphology. NPCs of the SVZ are derived from the neural plate and 
resemble radial glia, whereas NPCs of the OE are derived from the neural placode and 
are flat or rounded in shape, although they appear to adopt a radial phenotype upon injury 
(Suzuki et al, 2013; Barry et al 2014; Brann et al, 2015). These populations, respectively, 
produce interneurons or projection neurons throughout life. SVZ neuroblasts migrate 
through the rostral migratory stream to the olfactory bulb (OB) where they differentiate 
and integrate as interneurons of the periglomerular or granule cell layers (Lledo et al, 
2008). The cell bodies of newborn neurons in the OE migrate only a short distance 
apically towards the nasal cavity, before extending long axons to the appropriate location 
in the OB. Regeneration in the OE is of interest because of the projection neurons 
produced, as well as for the ease of access to NPCs in the nasal cavity for biopsy and 
possible transplantation. 
Cell Types and Organization of the Olfactory Epithelium 
Two different populations of NPCs, horizontal basal cells (HBCs) and globose 
basal cells (GBCs), give rise to all other cell types of the OE (reviewed in Brann and 
Firestein, 2014). As with other epithelia, the OE is made up of distinct cell layers that can 
be distinguished by cell morphology and cell specific markers (Figure 1). HBCs adhere to 
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the basal lamina, proliferate slowly, and self-renew (Mackay-Sim and Kittel, 1991). They 
express Intercellular Adhesion Molecule 1 (ICAM1), Cytokeratin 5 (KRT5), and an 
isoform of Tumor Related Protein (Np63).  
 
 
 
Figure 1. Cell Layers of the Olfactory Epithelium and Coronal Tissue Section. (A) 
Horizontal basal cells (HBCs; pink) and Globose basal cells (GBCs; orange) form distinct 
cell layers and give rise to immature olfactory sensory neurons (OSNi; green) and 
sustentacular cells (Sus; red). The mature OSNs (OSNm; blue) have dendrites that 
terminate in cilia (where odorant receptors and the sensory signal transduction apparatus 
are expressed) exposed to the nasal passage. OSNm also have axonal projections to the 
olfactory bulb (OB). Sus cells provide support to the neurons and are a type of glial cell. 
(B) The OE lines the nasal cavity and is supported by a complex boney structure to 
increase surface area for odorant detection. Looking at a coronal section, the epithelium 
wraps around in what are called turbinates and also along the middle structure called the 
septum which curves into the dorsal recess. The dorsal recess/septum (yellow) will be 
compared to turbinate (light green) in this study. The neurons in the dorsal recess/septum 
express more evolutionarily ancient odorant receptors compared to other zones of the OE. 
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GBCs are restricted to a layer directly above the HBCs and share many 
similarities with embryonic progenitor cells. They express transcription factors associated 
with neural differentiation including: Achaete-Scute Homolog 1 (ASCL1) and 
Neurogenin 1 (NGN1). Most GBCs cycle rapidly, generating new cells, some of which 
mature and integrate into the tissue, while the remainder undergo apoptosis. There is 
however a small segment of the GBC population that progresses more slowly through the 
cell cycle to self-renew (Jang et al., 2014). Down-regulation of Np63 transitions HBC to 
GBC, changing the reserve status or quiescence of the cell (Schnittke, 2015).  
Cells produced by NPCs migrate apically as they differentiate into olfactory 
sensory neurons (OSNs) or glial sustentacular cells (Sus). Immature OSNs (OSNi) 
express many factors common to immature neurons such as Growth Associated Protein 
43 (GAP43) and Doublecortin (DCX); mature OSNs (OSNm) are distinguished by 
expression of the signal transduction machinery necessary for odorant detection 
including: Adenylate Cyclase III (ADCY3), Olfactory G-protein (GNAL/Golf), Cyclic 
Nucleotide Gated Channel Alpha 2 (CNGA2), and also by Olfactory Marker Protein 
(OMP). OSN cell bodies are in the middle layers of the epithelium and extend dendrites 
to the nasal cavity. Sus cells express Epithelial-Cadherin (ECAD), Cytokeratin 18 
(CK18), as well as factors shared with NPCs, such as Sex Determining Region Y-Box 2 
(SOX2). Sus have apical cell bodies and send projections basally, terminating in end-feet 
that surround the NPC populations (Figure 1).  
Injury Response in the Olfactory Epithelium 
There is regular turnover of OSNs in the OE, but the extent to which regeneration 
is possible after severe damage is an object of intense study. In general, the olfactory 
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sensory circuit can be recapitulated and function restored as long as the OB target 
remains intact. All neurons expressing the same odorant receptor synapse with mitral 
cells in the OB in spherical structures known as glomeruli (reviewed in Mombaerts, 
2006). When the olfactory bulbs are surgically removed (olfactory bulbectomy or OBX), 
HBCs may or may not be recruited, but GBCs actively generate new OSNi that, when 
unable to synapse onto the OB also degenerate and a repetitive cycle begins (Leung et al, 
2007; Iwai et al, 2008).  
Chemical lesion on the other hand, commonly experimentally induced by 
exposure to methyl bromide gas or the anti-thryroid drug methimazole, spares the OB but 
induces massive cell death in the OE. For this reason, it is thought that HBCs are 
recruited to reconstitute the depleted cell types of the OE. Basal cell proliferation peaks 
approximately five days post-lesion, as indicated by bromodeoxyuridine (BrdU) mediated 
birth dating and by the thickness of the HBC layer which expands to two to three times 
its usual thickness (Leung et al, 2007), while at this time OSN marker labeling is at a low. 
The numbers of OSNi and OSNm start to increase after seven days post lesion and cell 
proliferation returns to control levels in four to six weeks. It takes about eight weeks for 
recovery to be complete (Schwob et al, 1995).  
A Disintegrin and Metalloprotease (ADAM) Family 
Changes in gene expression during critical periods of NPC activity may permit 
insight into what permissive factors are present in the OE that support neural 
regeneration. For the following project, I identified gene candidates which I hypothesized 
to be important for NPC maintenance and activation based on their expression in the 
literature. A member of A Disintegrin and Metalloprotease (ADAM) family, ADAM23, 
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was selected for further study. ADAMs are cell-signal, cell-adhesion, signal transduction 
proteins involved in processes such as proliferation, differentiation, and guidance, but 
they have not been studied to a great extent in the OE. 
Conserved Protein Domains 
ADAM1 and ADAM2, also known as Fertilin-alpha and beta, are transmembrane 
proteins necessary for sperm migration and sperm-egg binding respectively. They share 
conserved domain structures with a family of soluble proteins found in snake venom 
called the Metalloproteinase, Disintegrin-like, Cysteine-rich (MDC) family. Snake 
venom MDCs digest extracellular matrix (ECM) proteins, similar to the cell secreted 
Matrix Metalloproteinases (MMPs), but their effect is hemorrhagic, breaking down the 
basal lamina of blood vessel walls. The disintegrin domain binds integrins and prevents 
blood coagulation (Kamiguti et al, 1998). The ancient Hebrew name for the first man, 
ADAM, was therefore chosen, not only as an acronym for two specific protein domains, 
but as a nod to the role of some ADAMs in male fertility and their connection to snakes 
(Wolfsberger et al, 1995).  
In addition to the conserved metalloprotease and disintegrin domains, ADAMs 
have epidermal growth factor (EGF)-like and cysteine-rich domains, a transmembrane 
region, and a cytoplasmic tail (Figure 2A). ADAMs with a functional metalloprotease 
domain act as ectodomain sheddases (Figure 2C). ADAM10 and ADAM17 notably 
cleave cadherins, TNF-alpha and Notch receptors (Reiss et al, 2005; Hikita et al, 2009; 
Bozkulak et al, 2009). Catalytically inactive ADAMs include some primarily expressed 
in the testis (ADAM2, 3, 4, 5, 6, 18, 29, 32) as well as those expressed in the brain 
(ADAM11, 22, 23) (Choi et al, 2004; Sagane et al, 1998). These act primarily as cell-
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adhesion proteins. The disintegrin domain is known to bind to integrins, to leucine rich 
glioma inactivated (LGI) proteins (Sagane et al, 2008; Seppala et al, 2011), and evidence 
suggests interactions with other unidentified binding partners (Bridges, 2008). The 
disintegrin domain is important for cell adhesion (Cal et al, 2000), guidance (Huang et al 
2003), proliferation (D’abaco et al 2006), and differentiation (Lafuste et al, 2005; 
Kawaguchi et al, 2003). Both the metalloprotease and disintegrin binding sites are 
inactive until the prodomain is cleaved. The EGF-like domain is likely involved in 
protein-protein interactions and may help ADAMs to form heterodimers. The cysteine-
rich domain has been shown to facilitate cell-adhesion through interactions with 
syndecans and fibronectin (Iba, 2000; Gaultier 2002).  
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Figure 2.  ADAM Family of Proteins. (A) Adam domains common to all family 
members. Signal peptide (Sig, red), Prodomain (Pro, orange) which is cleaved prior to 
insertion in the membrane, Metalloprotease (Met, yellow) which depending on the 
ADAM may or may not be catalytically active, Dinsintegrin (Dis, light green) binds to 
integrins and other proteins, Cystein rich domain (Cys, dark green) involved in protein 
binding, Epidermal growth factor-like (EGF, light blue) domain involved in protein 
binding, Transmembrane (Trans, pink) region spanning the membrane, Cytoplasmic tail 
(Cyt, periwinkle) for signal transduction. (B) Predicted Adam23 splice variant sequences 
in mouse and their alignment. The identified transmembrane regions are highlighted in 
pink. (C) The linear protein is processed before insertion in the membrane. The Dis 
domain binds to integrins (dark blue). Those ADAMs with a functional Met domain 
cleave ectodomains (purple) from proteins such as TNFα and Notch receptors. 
 
Between members of the ADAM family there is about 30% protein sequence 
identity across all conserved domains. For some ADAMs there are multiple splice 
variants which have identical extracellular domains but different transmembrane regions 
and cytosolic tails. ADAM23 exhibits four primary splice variants (Figure 2B), likely 
with different roles in signaling. ADAMs are involved in both “forward” outside-in and 
“reverse” inside-out signaling (Tanaka et al, 2004). The cytosolic tail interacts with 
proteins via a sarcoma homology 3 (SH3) docking sequence (Kleino et al, 2015). It 
activates Phosphoinositide 3 Kinase (PI3K) (Kang et al, 2000; Kang et al, 2001), Focal 
Adhesion Kinase (FAK) (Böhm et al, 2013; Fried et al, 2015), and Extracellular-Signal 
Regulated Kinase (ERK1/2) (Sun et al, 2010) pathways that are involved in cell cycle 
regulation and cytoskeletal reorganization. 
ADAMs of Interest in the Olfactory Epithelium  
Each ADAM possesses an integrin binding domain and a transmembrane region 
facilitating signal transduction. Protein localization studies show integrins, which 
regulate cell interactions and mitosis, present in both HBCs and Sus cells (Carter et al, 
2004). ADAMs present in the OE could potentially bind integrins on either cell type. 
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HBCs are flattened on the basal lamina until they start to proliferate and move apically, 
becoming more rounded in shape. Given that ADAMs are tied to both cytoskeletal 
reorganization and cell cycle progression, they are a likely candidate for HBC regulation.  
For the most part ADAMs in the OE have not been studied. Previous work has 
shown the catalytically active ADAM10 protein is localized to neurons and basal cells 
(Yavari et al, 1998). In another study, ADAM21 was shown to be in immature OMP-
negative axons innervating the olfactory bulb, and metalloprotease inhibitors were 
labeled in the periglomerular area indicating that ADAM21 could be important for OSN 
axon guidance. In the SVZ, ADAM21 is expressed in cells of the subependymal and 
ependymal layers, in potential NPCs and glial cells that have projections onto blood 
vessels (Yang et al 2005).  
This project is the first to examine the expression and regulation of a catalytically 
inactive ADAM in the OE. ADAM23 was identified from three independent microarray 
experiments of a recovery time-series post-bulbectomy (Heron et al, 2013; Shetty et al, 
2005; Borders et al, 2007). I hypothesized that genes significantly different in expression 
days one through five of the series could be involved in activation of the basal 
populations. ADAM23 is essential for neural development. Knockout mice exhibit severe 
ataxia and tremor, and die within two weeks of birth (Mitchell et al, 2001). ADAM23 has 
been studied in pluripotent stem cells as an integral part of stem cell maintenance. P19 
carcinoma cells usually require both cell aggregation and retinoic acid (RA) for induction 
of a neural cell fate decision. When ADAM23 was knocked down in the embryonic stem 
cell line, neural differentiation occurred without induction by RA (Sun et al, 2007; Wang 
et al, 2012). Knockdown arrested progression through the cell cycle, keeping a higher 
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percentage of cells in the G1 phase, a key step before differentiation. The inhibitory 
effect of ADAM23 on differentiation was recapitulated by application of the purified 
GST-tagged disintegrin domain to ADAM23 knockout cells, indicating that signal 
transduction occurred through ADAM23’s interaction partner, likely a beta-1 integrin 
(Wang et al, 2012). ADAM23’s role in cell cycle arrest is further demonstrated by its 
frequent silencing in cancer cells, promoting metastasis (Verbisck et al, 2009). ADAM23 
could likewise regulate NPC activation and differentiation in the OE.  
Rationale for the Proceeding Experiments 
After identifying Adam23 as a gene of interest for NPC regulation, I designed 
primers to detect the presence or absence of transcript in OE tissue. Having confirmed 
transcription, I focused on determining the cellular localization of ADAM23 protein. I 
then asked whether Adam23 transcript and protein levels are dynamically regulated 
during postnatal development, as proliferation declines, or during recovery from injury, 
as proliferation is induced. If ADAM23 were important for maintaining a quiescent NPC 
population in the OE, then it should be stably expressed between postnatal days 30-60 
and upon injury it should be down-regulated one to three days following injury. As will 
be discussed, my results provide evidence for ADAM23’s potential role in inhibiting 
proliferation through cell-cell interactions.  
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CHAPTER TWO 
MATERIALS AND METHODS 
Animal Care & Sources 
All experiments were done in compliance with Loyola University of Chicago 
Institutional Animal Care and Use Committee guidelines in C57BL/6, SVE/129 wild-
type inbred mice, or OMP-GFP heterozygotes ages 4-12 weeks. The OMP-GFP mice are 
a targeted knockout reporter strain with 129P2/OlaHsd background and high expression 
of GFP (Potter et al, 2001). Mice were anesthetized by intraperitoneal injection with a 
mixture of ketamine/xylazine (0.05-0.15 mL of 18 mg/mL, and 2 mg/ml, respectively).  
Immunohistochemistry (IHC) 
Mice were anesthetized then perfused transcardially with heparinized PBS (4 
U/mL) and 3% PFA/0.1% glutaraldehyde in 0.1M PB. Tissue was decalcified in 0.5 M 
EDTA (pH 8.0), cryopreserved in 30% sucrose, and embedded in Tissue-Tek OCT 
(Sakura Finetek, Torrance, CA). Cryosections (12 µm) were warmed 10 min, hydrated in 
PBS 10 min, blocked in 3% H2O2 30 min, Avidin/Biotin block 10 min each (Invitrogen, 
Carlsbad, CA), and 10% Normal Donkey Serum (NDS)/0.1% Triton in PBS for 1 hr, 
followed by incubation with primary antisera recognizing ADAM23 (SC50482, 1:200, 
Santa Cruz, Dallas, TX), ICAM (AF583, 1:100, requires antigen retrieval 5 min in 
steamer with sodium citrate before block, RD Biosystems, Minneapolis, MN), ECAD 
(U3254, 1:500, Sigma Aldrich, St. Louis MO), or DCX
12 
 
(SC8066, 1:200, Santa Cruz) overnight at 4°C. After 16-18 hr primary incubation, tissue 
sections were exposed to secondary antisera 90 min at room temp (donkey anti-rabbit 
biotin 1:500, donkey anti-goat 488 1:300, goat anti-rat 633 (1:750) extra block step with 
10% Normal Goat Serum, donkey anti-goat 633 1:750). TSA amplification for ADAM23 
was done according to the manufacturer’s protocol (TSA kit #24 1:100, 1:100, Molecular 
Probes, Eugene, OR). Slides were rinsed after secondary incubation 3 x 5 min with PBS 
and incubated with horseradish peroxidase conjugated anti-biotin 1:100 in 10% NDS/ 
0.1% Triton in PBS for 60 min. Slides were rinsed 3 x 5 min with PBS and incubated 
with tyramide-568 1:100 in amplification buffer with 0.0015% H2O2 for 10 min. Slides 
were then rinsed 3 x 5 min in PBS. DRAQ5 or TOTO diluted 1:10K in PBS was applied 
for 15min before rinsing again 3 x 5 min. Slides were cover-slipped with Vectashield 
(Vector Laboratories, Burlingame, CA) and images acquired on an Olympus Fluoview 
1000 confocal microscope (Olympus America, Center Valley, PA) then subsequently 
analyzed with Image J software (NIH, Bethseda, MD) and the UCSD plugin. 
Immunocytochemistry (ICC) 
OE tissue was dissected on ice in Earle’s Balanced Salt Solution (EBSS) and 
broken up with forceps. The tissue was dissociated using a Papain Dissociation System 
(Worthington Biochemical Corp, Lakewood, NJ) according to the manufacturer’s 
instructions. Incubation with papain and a DNase enzyme in EBSS was for 45-60 min on 
a rocker at 37°C speed 90. The cells were triturated, centrifuged, re-suspended in EBSS 
with ovomucoid papain inhibitor, and plated onto laminin coated coverslips. Cultures 
were kept at 37°C in a CO2:O2 incubator for 60 min before fixing with 4% PFA in 0.1M 
PB for 15 min. Cells were blocked in 5% NDS/0.1% Triton for 30 min, incubated with 
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primary antisera in PBS for 1 hr at room temperature or overnight at 4°C (rabbit anti-
ADAM23 1:50), secondary for 45 min at room temp (donkey anti-rabbit 568 1:750), and 
DRAQ5 1:10K. Slides were cover-slipped with Vectashield and images acquired on an 
Olympus Fluoview 1000 confocal microscope, then analyzed with the Fiji Image J 
Package and the Analyze Particles plug-in (Schindelin et al, 2012).  
ICC Statistical Analysis 
 Using the Analyze Particles plug-in, I made a mask for each channel which could 
be applied to the others for detection of overlapping particles. The number of cells co-
labeled for a given set of markers was divided by the number of cells positive for a single 
marker. This gave a proportion of co-labeled cells. Proportions can be either log or 
arcsinsqrt transformed to obtain a Gaussian distribution. There are often zeros in cell 
count data which makes the arcsinsqrt transformation a better option. I performed a 
student’s t-test using GraphPad Prism 7 (GraphPad Software Inc, La Jolla, CA). 
Lesion of the Olfactory Epithelium 
 
Mice were administered either 50 mg/kg Methimazole (Sigma) or the same 
volume per weight of saline in a randomized manner via intraperitoneal injection. Mice 
were monitored daily for a week after injection for weight loss induced by drug 
administration and were euthanized if 20% or greater weight loss was observed. 
Microarray Data Mining 
The Gene Expression Omnibus (GEO) database is a repository of high-throughput 
genomics data supplied by members of the scientific community and made available to 
the public. Three microarray studies from the database were selected and analyzed 
(Heron et al, 2013; Shetty et al, 2005; Borders et al, 2007) with GEO2R (Edgar et al, 
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2002), an online tool which compares user-selected groups with correction for multiple-
tests. All three studies examined the time-course of recovery in mouse OE, following 
olfactory bulbectomy. From a long list of genes, found to change in expression early 
post-bulbectomy, ten short-list candidates were selected using the MGI Gene Ontology 
tool (Jackson Labs, Barharbor, ME). These genes were involved in processes such as 
cell-signaling, signal transduction, proliferation, differentiation, and cell-adhesion in 
other tissues.  
Primer Design 
Target sequences were obtained from the NCBI nucleotide database. Primers 
were designed using NCBI Primer Blast with a product size between 110-150 bp and 
melt temp between 57-63°C. When possible primers were separated by at least one intron 
on the genomic DNA. Primers were blasted against the genome reference assembly to 
check for specificity to mRNA sequences. Primers were analyzed using Oligoanalyzer 
before ordering (Integrated DNA Technologies Inc, Coralville, IA) where ΔG was no less 
than -10 kcal/mol for hairpin, self-dimer, and heterodimer formation.  
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
OEs were rapidly dissected and placed in RNAlater (Qiagen, Valencia, CA) and 
stored 24 hrs after isolation at -80°C until homogenized using RNase-Free Red Bead 
Lysis Kit tubes and a Bullet Blender (Next Advance, Averill Park, NY). RNA was 
extracted using a RNeasy Micro Kit (Qiagen) according to the manufacturer’s protocol. 
Excess RNAlater was removed from tissue, and tissue was weighed and divided with less 
than 5 mg per Red tube. To each tube 1ml RLT buffer from the RNeasy kit and 10 L -
mercaptoethanol was added before blending 3 min on speed 8 at 4°C. Samples were 
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centrifuged 3 min at 14,000 rpm and the supernatant removed. 700 L of 70% ethanol 
was added to the supernatant, mixed by pipetting, and transferred to a RNeasy MinElute 
spin column. The columns were centrifuged 15 sec at 13,400 rpm. The flow through was 
collected and each column placed in a new collection tube. Each column was washed 
with 350 L of Rneasy RW1 and columns were centrifuged for 30 sec at 13,400 rpm. 
From the RNeasy kit 3,220 l of Buffer RDD was added to 460 L of DNase1 and mixed 
by inversion, then 80 l of this DNase solution was added directly to the membrane of 
each column and allowed to incubate 15 min at room temperature, followed by a wash 
with 350 L of Rneasy RW1 buffer, and centrifugation for 30 sec at 13,400 rpm. The 
flow through was discarded and 500 ul of RNeasy RPE buffer working stock was added 
to each column and centrifuged 30 sec at 13,400 rpm. Flow through was discarded and 
500 ul 80% ethanol was added to the column and centrifuged 2 min at 13,400 rpm. Flow 
through was discarded and columns were dried before adding 14 ul of RNase free water 
to each membrane and centrifuged 1 min at 13,400 rpm. The eluted RNA samples were 
then stored at -80°C. RNA quality was verified using a Nanodrop spectrophotometer to 
obtain a 260/280 nm ratio of approximately 2.0 (Thermo Fisher, Waltham, MA). A 
Superscript III First Strand Synthesis Kit (Thermo Fisher) was used to generate cDNA 
from purified RNA. The presence or absence of target transcripts was determined by 
running PCR (2x Mastermix: Promega, Fitchburg, WI) at 95°C for 3 min, followed by 30 
cycles of 95°C for 30 sec, 60°C for 30 sec, 72°C for 45 sec, then 72°C for 7 min on a 
T100 thermocycler (Bio-Rad, Hercules, CA). The PCR product was run on a 20% 
acrylamide gel in 1x TAE at 100V for 45 min and imaged with an Odyssey FC imaging 
system (LI-COR, Lincoln, NE).  
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Real Time Quantitative Polymerase Chain Reaction (RT-qPCR) 
Olfactory epithelia were dissected and stored as described above until 
homogenized using Tri-reagent RT (MRC Gene, Cincinnati, OH). Tissue was weighed to 
be less than 100 mg before blending in 1 ml Tri-reagent RT in the Bullet blender on 
speed 8 for 5 min at room temperature. The samples were then centrifuged at 14,000 rpm 
for 3 min at 4°C. The supernatant was transferred to a new tube and 50 l 4-bromo 
anisole was added for phase separation after shaking 15 sec. Samples were centrifuged 
12,000 g for 15 min at 4°C. The aqueous phase was transferred to a new tube for a 
second phase separation with another 800 l Tri-reagent RT and 50 l 4-bromo anisole. 
The interphase and phenol phase were stored at 4°C for protein isolation 24 hrs later. 
After the second separation the aqueous phase was transferred to a new tube and 800 l 
isopropanol was added to precipitate the RNA. The samples were allowed to set for 10 
min at room temperature then centrifuged 12,000 g for 5 min at 4°C.  The supernatant 
was discarded and the pellet was washed by adding 1 ml 75% ethanol and vortexed 
before centrifuging 12,000 g for 5 min at 4°C. The supernatant was discarded and the 
wash step repeated before dissolving the pellet in 600ul water and storing at -80°C.   
A High Capacity RNA-to-cDNA Kit (Applied Biosystems, Foster City, CA) was 
used to generate cDNA. To optimize the PCR reaction, to avoid primer dimer formation 
as seen by gel electrophoresis, the Amplitaq Gold Fast PCR mastermix was used 
(Applied Biosystems, Foster City, CA)) at 95°C for 10 min, followed by 35 cycles of 
96°C for 3 sec, 60°C for 3 sec, 68°C for 5 sec, and then 72°C for 10 sec. To optimize 
primer concentrations for a reaction efficiency of 100 ± 10%, a five-point dilution of 
sample RNA was used to generate cDNA, and standard curves for each primer pair were 
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run using Power-Up Syber Green Mastermix (Applied Biosystems) on a Step-One Plus 
Real-Time PCR machine (Applied Biosystems) at 50°C for 2 min, followed by 40 cycles 
of 95°C for 2 min and 60°C for 30 sec, then 95°C for 15 sec, 60°C for 1 min, and 95°C 
for 15 sec. For relative quantification of the genes of interest two house-keeping genes 
were selected to use in combination using Normfinder (Andersen et al, 2004). A reaction 
plate, with three genes and three technical replicates for each experimental condition, was 
run for each biological replicate using the Power-UP Syber and Step-One Plus machine. 
The primer sequences and concentrations can be found in Table 1.   
 
Table 1. RT-qPCR Primers 
 
Gene Forward Reverse µM bp 
Pgk1  
NM_008828.3 
TGGTGGGTGTGAATCTGCC ACTTTAGCGCCTCCCAAGATA 50 124 
Tfrc 
NM_011638.4 
CATTGCGGACTGTAGAGGCG TTGCCGAGCAAGGCTAAACC 50 134 
Adam23v2 
NM_011780.2 
CCAGTTCGGAACCCCAACC CTCCTCTTCTTGACGTTTTTA
AATCCC   
100 150 
Adam23x1 
XM_006495969.1 
GGGTGATTTTTGGAGGCACAG CCAGAACCCAACAGTGCAAG 100 128 
Adam23x2 
XM_006495970.1 
GGTGTGTAGCAACGAAGCCA CTTCTTGACGTTTCCTTAGGG
C 
100 126 
Adam23v1 
NM_001177600.1 
GCCACGGGGTGTGTAGCA GCAGTGATCTAAAACCGGAA
TCAT 
100 150 
Adam23x3 
XM_006495971.1 
CCAGTTCGGAACCCCAACC GTATTCCAGGCAGGCAGATG
A 
100 124 
Adam4 
NM_009620.1 
AGCAATTCCTCCACCTCAGT CGGGGACAGTATGCAGGTTC 50 136 
Adam21 
NM_020330.4 
GCCTGCACAGAGGTTATGGA GCCCAGCTATGAGCAGACAA 50 129 
Adam10 ATGGTGTTGCCGACAGTGTTA  GTTTGGCACGCTGGTGTTTTT  50 151 
Adam2 
NM_009618.2 
CACAGCGGATCGTCTCTCAC GCATTTGCCAGTCCAATCAAC
T 
50 127 
Adam2x1 
XM_006518439.1 
CCCCCAACTGCCCTGTAGA ATTTCTCACGAGTGCCTTCTG
T 
50 148 
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ΔNp63 
NM_001127265.1 
NM_001127264.1 
NM_001127263.1 
NM_001127262.1 
NM_011641.2 
TGTACCTGGAAAACAATGCCC 
 
 
CGCTATTCTGTGCGTGGTCT  
 
50 141 
 
Ascl1* 
NM_008553.4 
TCGTTGGCGAGAAACACTAA AGGAACAAGAGCTGCTGGAC 50 120 
Ecad 
NM_009864.3 
CCGTCCTGCCAATCCTGATG TGCCCTCGTAATCGAACACC 100 116 
Gap43* 
NM_008083.2 
CTGCTGCTGTCACTGATGCT GGCTTCGTCTACAGCGTCTT 50 131 
Omp* 
NM_011010.2 
GTCCAGAACCACGTTCCAGT GGAGAAGAAGCAGGATGGTG 100 112 
*(Fletcher, 2011)  
 
RT-qPCR Data Analysis 
 The output of the StepOne Plus software version 2.3 calculated differences in 
cycle times (ΔCT) between a gene of interest and the mean of two reference genes Pgk1 
and Tfrc. I transformed these into relative expression values 2^- ΔCT by assuming 100% 
reaction efficiency. I then normalized each lesion condition to a saline control to obtain 
the fold change in expression post-lesion. I log transformed the fold change data to fit a 
Gaussian distribution for parametric statistical analysis. A One-way ANOVA and 
Tukey’s multiple comparisons test was performed using GraphPad Prism 7 statistical 
software. 
Solutions and Reagents 
Phosphate Buffered Saline (PBS): 10 mM PO4
3−, 137 mM NaCl, and 2.7 mM KCl. 
Phosphate Buffer (0.2M PB): 0.2 M NaH2PO4 (monobasic), 0.2 M Na2HPO4. 
Electrophoresis Buffer (TAE): 40 mM Tris base, 20 mM Acetic Acid, 1 mM 
Ethylenediaminetetraacetic acid (EDTA). Tank buffer for Western blot: 25 mM Tris base, 
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192 mM glycine, in 10% SDS and 20% methanol. Blotting Buffer for Western blot: 25 
mM Tris base, 192 mM glycine, in 0.1% SDS and 20% methanol.  Tris-buffered saline 
(TBS): 44.5 mM Tris HCl, 5.5 mM Tris base, 150 mM NaCl, 2.4 mM CaCl2. Anti-
ADAM23: The rabbit polyclonal antibody was affinity purified. It was splice variant non-
specific, targeting a conserved region in the Disintegrin domain.  
Western Blotting 
The remaining aqueous phase from RNA isolation was carefully pipetted off the 
interphase and phenol phase which had been stored overnight at 4°C prior to adding 300 
uL of 100% ethanol and mixing by inversion. The samples were allowed to set 3 min at 
room temp before centrifuging 2,000 g for 5 min at 4°C. Supernatants were split between 
two tubes (~300 μl each) before adding 3x volume of isopropanol. The tubes were mixed 
by inversion for 15 sec and allowed to set at room temp 10 min before centrifuging 
12,000 g for 10 min at 4°C. Supernatants were discarded and 1 ml of 300 mM guanidine 
hydrochloride and 2.5% glycerol in 100% ethanol, a wash solution (GH), was added. The 
pellets were broken up manually with a syringe needle, vortexed, and allowed to incubate 
for 10 min at room temp before centrifuging 8,000 g for 5 min at 4°C. This wash step 
was repeated 2x and samples could be stored in the GH solution at -80°C and prepared 
further before use. A wash with 1ml 2.5% glycerol in 100% ethanol was performed then 
samples were vortexed, allowed to set 10 min at room temp, and centrifuged 8,000 g for 
5 min at 4°C. The pellet was solubilized in 1% sodium dodecyl sulfate (SDS) in PBS 
with protease inhibitors: 1 μg/mL pepstatin A, 1 μg/ml leupeptin, 2 μg/mL aprotinin, 10 
μg/mL phenylmethylsulfonyl fluoride, and 10 mM Na3VO4. For equal loading of 
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Western lanes a Pierce BCA protein assay kit (Thermo Fischer) was used to quantify 
sample protein concentrations.  
Samples were heated for 5 min at 95°C, cooled on ice 1-2 min, and centrifuged 
before running on a 30% acrylamide gel in tank buffer for ~1 hr at 150V. Gels were 
soaked in blotting buffer for 15 min and transferred to nitrocellulose at 100V for 90 min. 
Blots were rinsed in water and incubated in 700 nm REVERT total protein stain (LI-
COR) for 5 min, rinsed with REVERT wash solution, and imaged on an Odyssey FC 
imaging system (LI-COR). The REVERT reversal solution was applied for 5 min. Blots 
were then rinsed with water and washed 3 x 10 min in TBS, 3 x 10 min in TTBS, and 
blocked for 1 hr in 1:1 Odyssey blocking buffer (LI-COR) and TBS. The anti-ADAM23 
primary anti-body was diluted 1:500 in Odyssey block:TBS with 0.2% Tween-20 and the 
blot was allowed to incubate overnight at 4°C. It was washed 3 x 10 min in TBS 0.2% 
Tween-20 (TTBS) and incubated with 800 nm donkey ant-rabbit secondary (LI-COR for 
90 min at room temp. It was then washed 3 x 10 min in TTBS, 3 x 10 min in TBS, and 
re-imaged. The blot was blocked in 1:1 Odyssey block:TBS for 1 hr before re-probing 
with mouse anti-Tubulin antibody (1:2000) in 1:1 Odyssey block:TBS with 0.2% Tween-
20 overnight at 4°C. Blots were washed 3 x 10 min in TTBS and incubated 90 min in 680 
nm donkey anti-mouse secondary (LI-COR) 1:5000 in 1:1 Odyssey block:TBS with 0.2% 
Tween-20. It was again washed 3 x 10 min in TTBS, 3 x 10 min TBS, and imaged.  
Western Blot Data Analysis 
 In Image Studio software (LI-COR) version 5.2, the Western blot analysis tools 
was used to measure signal strength in lanes (total protein) and bands (ADAM23, α-
tubulin) by drawing rectangular shapes. The median background in the gel was 
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subtracted. The images were also analyzed in Image J using the gel analysis tool to select 
spatial peaks in density from each lane for comparison. This involved drawing lines to 
mark where peaks could be distinguished from background. There was a lot of 
background from remaining total protein stain. Relative densities were calculated for 
ADAM23 peaks and control peaks separately. The signal values and relative density 
measurements from total protein or α-tubulin controls were transformed into 
normalization factors (fraction of the highest value) by which ADAM23’s signal was 
divided. This normalized signal was then transformed into a fraction of the highest value 
within replicates so they could be averaged despite differences in scale. The normalized 
values for ADAM23 were compared across saline and lesion conditions and across days 
post-injection by performing a 2-Way ANOVA and Tukeys multiple comparison test in 
GraphPad Prism 7 statistical software.  
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CHAPTER THREE 
RESULTS 
In Silico Identification of Candidate Genes Involved in Regeneration 
I was initially interested in identifying genes that regulate neurogenesis and the 
regenerative capacity of NPCs in the OE. Therefore, I examined data from three separate 
microarray studies in the GEO database (Heron et al, 2013; Shetty et al, 2005; Borders et 
al, 2007) to identify genes expressed in the OE that are significantly different following 
injury. In these studies, OSN cell death and subsequent regeneration was induced by 
olfactory bulbectomy, a well characterized surgical method of OE lesion. I looked for 
altered gene expression (common to all three studies) using GEO2R, an online tool which 
analyzes differences between user-selected groups (control, days post-injury) with 
correction for multiple-tests. Several Adams exhibited a change in expression early post-
injury, within one to five days. Adam23 in particular decreased in expression in all three 
microarray studies (adj. pval<0.05), as early as day two. In one study, Adam22 decreased 
in expression by day five (adj. pval<0.05), while in another Adam4 and Adam10 
increased in expression by day two (adj. pval<0.05). I reviewed the current literature and 
determined if any of the gene candidates had the appropriate structure for signal 
transduction, were known to have interaction partners in the OE, were critical for nervous 
system development, or were implicated in stem cell regulation in other tissues (Carter et 
al, 2004, Mitchell et al, 2001, Sun et al, 2007; Wang et al, 2012). I identified Adam23 as 
the most promising of the gene candidates because of its involvement (along  
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with other Adam family members) in cell-cycle regulation (Verbisck et al, 2009, Kang et 
al, 2000; Kang et al, 2001, Sun et al, 2010).  
Adams are Expressed in the Olfactory Epithelium 
After, having selected Adam23 for further study, I designed primers for both its 
known and predicted splice variants along with primers for additional Adam family 
members (Table 1). After isolating mRNA from olfactory epithelia and transcribing 
cDNA from these transcripts, I used RT-PCR to detect the presence or absence of 
transcript in OE tissue. I found that four Adam23 splice variants are 
expressed in OE tissue as well as transcripts for Adam4, Adam21, and Adam10 (Figure 
3). I then focused my efforts on Adam23 due to the agreement between microarray 
studies and the results of the literature search. 
 
 
 
Figure 3.  Adams Expressed in the Olfactory Epithelium. cDNA generated from RT-
PCR of extracted RNA. Gel electrophoresis of PCR products. (L0) 50 bp ladder, (L1) 
Adam23v2, (L2) Adam23x1, (L3) Adam23x2, (L4) Adam23v1, (L5) Adam4, (L6) 
Adam21, (L7) Adam10.  
24 
  
As I had evidence that Adam23 transcripts were present in the OE, my next goal 
was to identify whether ADAM23 protein was detected in the OE. To this end, I used 
immunohistochemistry (IHC) to verify the presence of ADAM23 protein and its cellular 
localization in normal OE tissue which had been perfused and cryosectioned (Figure 4). 
Because there is evidence that different portions of the OE express different classes of 
odorant receptors (Bozza et al, 2009), different cell adhesion molecules (Yoshihara et al, 
1997), and therefore ADAM expression may not be uniform throughout, I compared 
expression in the dorsal recess and dorsal septum, also known as “Zone 1”, versus the 
ventral septum and nasal turbinates, generally referred to as “Zones 2-4” (Figure 1B). In 
the dorsal recess and along parts of the septum, ADAM23 expression was detected 
primarily in Sus cell bodies and in their processes extending down to the basal OE 
(Figure 4 A-H). Labeling in basal cells of the OE was inconsistent but coincided with 
zones of Sus labeling. For some turbinates, ADAM23 labeling was also found in neurons 
(Figure 4 I-P). Much of the protein detected appeared to be cytosolic in Sus cells and 
sometimes nuclear in neurons.  
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Figure 4. ADAM23 Expression in the Olfactory Epithelium. Immunofluorescence 
labeling of ADAM23 (red) in OMP-GFP transgenic mouse OE (green, mature neurons) 
with DRAQ5 (blue, nuclei marker), p15. Scale bar 25 µm. (A-D) ADAM23 localized in 
Sus cell bodies and processes along the septum near the dorsal recess. (E-H) Omission of 
anti-ADAM23 primary (control), view of septum near the dorsal recess. (I-L) ADAM23 
localization in neurons of turbinate. (M-P) Omission of anti-ADAM23 primary (control), 
view of turbinate.  
ADAM23 Co-localization with Sus and Neuron Markers 
Once I had evidence that ADAM23 protein is expressed in the OE, I next turned 
to confirming the cell type(s) that it is localized in. ADAM23 was co-localized with the 
Sus cell marker ECAD in the dorsal recess (Figure 5 A-H). When antigen retrieval was 
performed, ADAM23 still appeared primarily in Sus cells, though the processes were no 
longer visible and contact with the ICAM labeled HBCs was obscured (Figure 5 I-P). In 
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the turbinates, ADAM23 protein expression was detected in both immature neurons 
identified by their DCX expression, and in mature neurons identified by GFP expression 
in the OMP-GFP transgenic reporter mouse (Figure 6 A-P). To quantify the percent of 
OE cells which are ADAM23 positive, and of those how many are neurons, I performed 
ICC on dissociated cells from OE tissue. Nearly all of the cells labeled for ADAM23 
were also positive for a nuclear marker (90.4 ± 0.079 %, n=4; Figure 7). There were 
1.74x more ADAM23 positive cells in cultures exposed to both the rabbit anti-ADAM23 
antibody and a secondary antibody versus those for which the primary antibody was 
omitted as a control (p<0.05, n = 4). However, in cells dissociated from the OEs of OMP-
GFP reporter mice, I did not detect any difference (0.99x) between the number of cells 
co-labeled with both ADAM23 and GFP in anti-ADAM23 treated cultures versus 
controls (n=4). 
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Figure 5. ADAM23 Expression in Sus with Projections to HBCs. Co-localization of 
ADAM23 (red) with Sus and HBC markers. Scale bars 25 µm. (A-D) ECAD (green, Sus) 
in dorsal recess of OMP-GFP mouse OE (blue, mature neuron), p20. (E-H) Comparison 
to omission of anti-ADAM23 and anti-ECAD primaries (control), view of dorsal recess. 
(I-L) ICAM (green, HBC) with TOTO (blue, nuclei) in septum near dorsal recess after 
antigen retrieval, p81. (M-P) Comparison to omission of anti-ADAM23 and anti-ICAM 
primaries (control), view of septum. 
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Figure 6. ADAM23 Expression in Neurons. Co-localization of ADAM23 (red) with 
mature and immature neuron markers. Scale bars 25 µm. (A-D) DCX (green, immature 
neuron) in dorsal recess of OMP-GFP mouse OE (blue, mature neuron), p19. (E-H) 
Comparison to omission of anti-ADAM23 and anti-DCX primaries (control), view of 
dorsal recess. (I-L) DCX (green, immature neuron) in turbinate of OMP-GFP mouse OE 
(blue, mature neuron), p19. (M-P) Comparison to omission of anti-ADAM23 and anti-
DCX primaries (control), view of turbinate. 
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Figure 7.  Proportion of OE Cells that Express ADAM23. Cells were dissociated with 
papain and plated. Comparison to omission of primary control. Scale bars 50 µm. (A) 
ADAM23 (red) with DRAQ5 (blue, nuclei). (B) Omission of anti-ADAM23 primary 
(red) with DRAQ5 (blue). (C) ADAM23 (red) with OMP-GFP (green, mature neurons). 
(D) Omission of anti-ADAM23 primary (red) with OMP-GFP (green). (E) Proportion of 
DRAQ5 positive cells also ADAM23 positive, arcsinsqrt transformed. Comparison 
between primary and omission of primary control. (F) Proportion of ADAM23 positive 
cells also positive for OMP-GFP, arcsinsqrt transformed. Comparison between primary 
and omission of primary control with t-test, n=4 *p<0.05. 
 
ADAM23 Expression Changes During Postnatal Development 
 While examining ADAM23’s expression in OE, I did not detect ADAM23 protein 
in tissue from mice of age p3-4 as compared to tissue from mice age p15 and older 
(Figure 8). Adam23’s expression during post-natal development is relevant to 
understanding its role in the OE. To this end I determined relative transcript expression 
using RT-qPCR (same primers, Table 1) after extracting mRNA from tissue at age p1, 
p5, p10, p15, p20, p30, p60, p120, and 12 months. The three Adam23 splice variants 
examined increase in expression between p1 and p15 (n=1). Expression of Adam23v2 and 
Adam23x2 increases through at least p120 (fold change = 7.49 and 2.37, respectively) and 
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likely asymptotes thereafter, whereas Adam23x1 expression peaks earlier at p10 (fold 
change = 2.80).  
 
 
Figure 8. ADAM23 Expression Changes During Postnatal Development. Comparison 
of ADAM23 expression between age p3-4 and p15. Scale bars 25 µm. (A-D) ADAM23 
(red) with OMP-GFP (green, mature neurons) and TOTO (blue, nuclei) in dorsal recess, 
p3-4. (E-H) ADAM23 (red) with OMP-GFP (green, mature neurons) and TOTO (blue, 
nuclei) in dorsal recess, p15. (I) RT-qPCR log(fold change) Adam23v2 expression 
increases during post-natal development (n=1). (J) RT-qPCR log(fold change) Adam23x1 
expression peaks at p10 during postnatal development (n=1). (K) RT-qPCR log(fold 
change) Adam23x2 expression increases during postnatal development (n=1). 
 
Adam23 Gene Expression is Altered as the OE Regenerates 
 After verifying the expression of Adam23 and its protein product in intact OE 
tissue, I performed RT-qPCR on tissue collected 1, 3, 5, 7-8, and 12-14 days post-
methimazole lesion, to determine whether Adam23 is differentially expressed during 
lesion recovery and how its pattern of expression compares to that of cell specific 
markers (Figure 9). All four Adam23 splice variants decreased in expression days 1-8 
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post-lesion before returning to control levels (log(FC) = -0.74, -0.69, -0.42, and -0.61). 
The decrease from control was not as dramatic as the decrease in the OSNm marker 
(log(FC)  = -1.35). The HBC marker, ΔNp63, increased in expression by day 3 post-
lesion (log(FC) = 0.55). The GBC marker, Ascl1, increased in expression with peak at 
day 5 post-lesion (log(FC) = 0.65). The Sus cell marker, Ecad, increased in expression by 
day 3 post-lesion (log(FC) = 0.24). The cell marker for OSNi, Gap43, decreased in 
expression days 1-5 post-lesion, before increasing days 7-12 (log(FC) = -0.60). The 
OSNm cell marker, OMP, decreased in expression days 1-7 post-lesion, before increasing 
by day 12 post-lesion. 
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Figure 9.  Adam23 Gene Expression is Altered Post-Lesion. Log transformed fold 
change in Adam23 splice variant and cell marker expression, as measured by RT-qPCR 
for days 1, 3, 5, 7-8, and 12-14 post-lesion, compared to saline controls. Expression was 
calculated using the 2^-ΔΔCT method with Pgk1 and Tfrc for reference genes. One-way 
ANOVA’s were performed followed by Tukey’s multiple comparison test. Asterisks are 
used to denote significant differences between a point and the point immediately 
preceding it (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). (A)(B)(C)(D) Adam23 
splice variants decrease in expression days 1-8 post-lesion before returning to control 
levels, n=6. (E) ΔNp63, an HBC cell marker, increases in expression by day 3 post-
lesion, n=4. (F) Ascl1, a GBC cell marker, increases in expression, with peak at day 5 
post-lesion, n=4. (G) Ecad, a Sus cell marker, increases in expression by day 3 post-
lesion, n=2. (H) Gap43, an OSNi cell marker, decreases in expression days 1-5 post-
lesion, before increasing days 7-12 post-lesion, n=4. (I) OMP, an OSNm cell marker, 
decreases in expression days 1-7 post-lesion, before increasing by day 12 post-lesion, 
n=4.  
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ADAM23 Protein Levels are Altered as the OE Regenerates  
 Next, I wanted to determine whether the changes observed in Adam23 mRNA 
expression are reflected in ADAM23 protein levels post-lesion. Protein was isolated from 
the same OE tissue samples that were used for RT-qPCR. The ADAM23 antibody used 
in IHC also recognized a band corresponding to the expected molecular weight (Mr = 90 
kDa) of ADAM23 in its preprotein form (Figure 10). In lanes for lesion day (L1), (L3), 
and (L5) another band is faintly seen which is likely the cleaved form of the protein (Mr 
= 71 kDa). Two methods of normalization were used. First, blots were exposed to a total 
protein stain prior to antibody incubations. However, the total protein stain was not 
completely reversible. Second, blots were probed with an antibody detecting tubulin after 
ADAM23 antisera incubation. The protein stain provides evidence for equal loading 
between lanes whereas α-tubulin and ADAM23 both change in expression level in 
alternating lanes. Normalizing to one versus the other yields opposite results. When 
normalizing to α-tubulin in Image J, ADAM23 protein levels are not different between 
lesion and saline conditions (FC = 0.83, 0.44, 0.45, 0.08, 0.40, days 1-12 respectively; 
n=4, 2-way ANOVA). When normalizing to total protein in either Image J or Image 
Studio, ADAM23 protein is significantly upregulated between lesion and saline control 
day 3 (FC = 2.43, p<0.05, n=4, 2-way ANOVA).  
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Figure 10. ADAM23 Protein Expression is Altered Post-Lesion. (A) Western blot 
showing ADAM23 (green, expected Mr = 70/90 kDa) and α-Tubulin (red, expected Mr = 
54 kDa) after total protein stain reversal. L0: Molecular weight marker (MW), S1: saline 
day 1, L1: lesion day 1, S3: saline day 3, L3: lesion day3, S5: saline day 5, L5: lesion day 
5, S7: saline day 7-8, L7: lesion day 7-8, S12: saline day 12-14, L12: lesion day 12-14. 
(B) ADAM23 protein expression in lesion and saline controls, normalized to α-Tubulin. 
Two-way ANOVA showed no significant differences between saline and lesion 
conditions or between days post injection (n=4, p>0.05). (C) ADAM23 protein 
expression in lesion and saline controls, normalized to total protein. Two-way ANOVA 
showed significant differences between saline and lesion conditions and between days 
post injection (n=4, p<0.01, p<0.05). Tukey’s multiple comparison test found a 
significant increase between day 1 and day 3 post-lesion (* p<0.05).  
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CHAPTER FOUR 
DISCUSSION 
My goal was to identify genes of importance in the OE for maintaining and 
activating the resident NPC populations. I hypothesized that such genes would be 
involved in cell signaling, signal transduction, and tie into pathways regulating the cell 
cycle in NPCs. I also expected such genes would be dynamically regulated during 
regeneration. The ADAMs are a family of proteins involved in these processes that I 
identified by examining published microarray expression data post-bulbectomy (Heron et 
al, 2013; Shetty et al, 2005; Borders et al, 2007). Adam23 expression in particular 
decreased in all three microarrays and is implicated in stem cell regulation (Sun et al, 
2007; Wang et al, 2012). First, I confirmed Adam23 expression in the OE, and observed 
that multiple splice variants were present. I then identified what cell types express 
ADAM23 protein, and finally I measured changes in mRNA and protein expression 
during times of cell death, proliferation, and regeneration.  
Multiple cell types express ADAM23 protein as labeled with IHC. ADAM23 is in 
both Sus cell bodies and along their basal processes. Interestingly, the contact of HBCs 
with Sus end-feet via primary cilia regulates regeneration in the OE (Joiner et al, 2015). 
Indeed, it has also been shown that Sus can induce basal cell proliferation via purine 
signaling (Hassenklover et al, 2008). It may be that the ADAM23:integrin interaction is 
disrupted during injury to sensitize NPC’s to other signals for repair in their environment.  
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ADAM’s interaction partners, the integrins, have not been fully characterized in 
the OE. A previous study demonstrated strong integrin labeling on the basal surface of 
HBCs (Carter et al, 2004). However, while the authors did not emphasize it, I also 
observed integrin immunoreactivity in Sus cell bodies. This provides support for a 
possible interaction between the ADAMs observed in mature neurons and integrin-
expressing Sus cells. Disruption of Neuron:Sus contact upon neuron death may activate 
signaling in Sus cell bodies traveling apical to basal (Miragall et al, 2004; Makino et al, 
2009). 
I did not observe Sus or neuron labeling in tissue sections from very young mice 
age p3-4. My preliminary RT-qPCR data is in agreement with my hypothesis that 
Adam23 is developmentally regulated, increasing in expression between p1 and p15. The 
RT-qPCR results for the splice variant Adam23x2 (gamma) did not follow the general 
pattern observed in a previous study with tissue from whole mouse brains. In that study, a 
variant named gamma, lacking a transmembrane domain, was expressed embryonically 
but was down-regulated by p10, while variants alpha and beta, differing in composition 
by 91 base pairs in the transmembrane region, were expressed into adulthood (Sun et al, 
2004).  
The sequences of these three variants correspond to reference sequences in the 
NCBI database named Adam23-variant2 (v2, beta), Adam23-predicted-variant1 (x1, 
alpha), and Adam23-predicted-variant2 (x2, gamma). These three were expressed in OE 
tissue along with Adam23-variant1 (v1). The Adam23-predicted-variant3 (x3) was not 
expressed. Both Adam23v1 and Adam23x3 have recently been removed from the database 
due to lack of experimental evidence. Adam23v1 is present in OE tissue, but whether it is 
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processed into protein remains an open question. It may, like Adam23x2 (gamma), be a 
soluble isoform secreted by the cell or cytosolic and compete with binding of ADAM23 
extracellularly and/or intracellularly.  
I observed that Adam23 expression decreased post-methimazole lesion, in 
agreement with the microarray studies post-bulbectomy. Even with this higher resolution 
look at the recovery time-series, days 1, 3, 5, 7-8, and 12-14 post-lesion, changes in 
expression cannot be tied to regulation in any one cell-type. By examining the expression 
of cell-specific markers the death and regeneration of OE cell-types can be marked. The 
overall decrease of Adam23 in OE tissue due to the death of neurons may mask any 
down- or up-regulation in surviving Sus and NPCs. It was unexpected that Sus cell 
marker Ecad should increase post-lesion, indicating that methimazole lesion may not 
cause much Sus cell death and Sus cells may proliferate immediately following lesion. 
The increase in HBC marker ΔNp63 by 3 days post-lesion, followed by a peak in GBC 
marker Ascl1 5 days post-lesion, and subsequent increases in Gap43 and Omp, 
recapitulates the timing of proliferation and recovery observed in previous Brdu 
experiments. This is the only study to use RT-qPCR and not microarray to observe 
changes in cell marker expression post-lesion. Our results agree with the microarray 
findings. Small changes in expression were more easily detected and replicated. The only 
other study which used RT-qPCR in the OE was limited to gene expression in FACS 
sorted HBCs (Fletcher et al, 2011).  
 Finally, I did not observe a corresponding decrease in ADAM23 protein levels 
post-lesion, as quantified in Western blot by normalization to α-tubulin. While the 
difference between the saline and lesion condition was not significant (n=4, p>0.05) due 
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to high variation, this could be resolved with a greater number of replicates. The absence 
of ADAM23 mediated cell-signaling post-lesion could in some way induce the repair 
response in the OE. Alternately, when normalized to total protein ADAM23 increases 
significantly (n=4, p<0.05) in conflict with the RT-qPCR data. This would mean that 
some other form of regulating the protein exists and that it is likely important for 
mediating cell-cell interactions during recovery of the stratified epithelium.  
 This work provides a basis for further study of ADAM23. I show evidence that it 
is expressed in the OE as both transcript and protein. That it has multiple splice variants 
and may be expressed in both Sus and neurons in a region dependent manner. I show that 
Adam23 mRNA expression decreases post-lesion in a pattern similar to expression of the 
mature neuron marker OMP. This information and the preliminary protein expression 
data will allow for an educated hypothesis about ADAM23’s functional importance in the 
OE and will guide the design of future experiments. Through study of ADAM23, the 
field of neural regeneration could gain a better understanding of the importance of 
Sus:NPC and Sus:neuron interactions in tissue repair. The cellular processes which can 
be regulated by a catalytically inactive member of the ADAM family through interaction 
with integrins is also of interest and could provide a missing link in the NPC activation 
cascade.  
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CHAPTER FIVE 
FUTURE DIRECTIONS 
From the evidence I have accumulated so far ADAM23 likely mediates signaling 
between Sus and NPCs and between Sus and neurons. Sus have not received much 
attention in the regenerating OE until recently. We know that Sus cell morphology 
changes post-injury (Makino et al, 2009), and contact between the primary cilia of NPCs 
and Sus cell end-feet is important for neurogenesis during post-natal development and 
during regeneration (Joiner et al, 2015). Characterizing the signaling mechanisms behind 
these cellular responses would be of significance in understanding why neural 
regeneration is supported throughout life in the OE. 
Before investigating the functional importance of ADAM23 in the OE, the 
localization of ADAM23 protein and its expression by Sus and neurons must be further 
supported. Localization to a particular cell-type has relied on the specificity of an 
antibody (SC50482, Santa Cruz). Immunogen pre-adsorption was not performed as a 
control since the immunizing peptide was not commercially available; however, we may 
be able to synthesize the peptide to perform these controls. The antibody could also be 
used for IHC on the ADAM23 knockout mouse (B6:129S5-Adam23tm1Lex) as another 
control for specificity. Tissue from a reporter mouse could be used to determine cellular 
expression (Tg(Adam23-EGFP)LR169Gsat/Mmucd). In addition to these methods, an in situ 
hybridization could be performed to examine mRNA expression and localization.  
In addition, IHC in saline and lesion condition tissue would be of interest to 
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to confirm the RT-qPCR expression findings. Reduced labeling of ADAM23 in Sus post-
lesion may coincide with markers of proliferation in the Sus themselves or in the NPCs. 
To support these results quantification of protein levels should be completed with equal 
loading and a reliable method of normalization. The RT-qPCR expression of Adam23 
during post-natal development should also be completed and compared to the onset of 
cell specific markers. An increase in Adam23 expression by p15 should coincide with a 
decline in proliferation and upregulation of genes such as Np63 known to control the 
reserve status of HBCs.  
 Co-localization of ADAM23 with Sus and neuron cell markers was observed in 
OE tissue. Further IHC could be performed showing co-localization with integrins or 
with LGI proteins. Immunoprecipitation could be used to identify ADAM23’s interaction 
partners. OE NPCs could be cultured and the ability to form neurospheres measured after 
application of ADAM23’s disintegrin domain, which could be used to either block the 
ADAM23 signal transduction cascade leading to increased differentiation or to activate 
its binding partners and promote self-renewal.  
Finally, to get at a function for ADAM23 in vivo a conditional knockout mouse 
(C57BL/6N-Adam23tm1a(EUCOMM)Hmgu/H) could be ordered, or knockout of ADAM23 in 
Sus cells, could be done using RNA interference or CRISPR/Cas9. The structure of the 
OE would be examined histologically for changes in the cell layers, in cell morphology, 
for displaced cells, and for increased or decreased OE thickness. The ability to recover 
from lesion may be impaired taking a longer time for recovery.  
A strong case could be made, having established expression, localization, 
interaction, and a conditional knockout phenotype, that ADAM23 is necessary for 
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regeneration. ADAM23 may demonstrate further the importance of Sus cell interactions 
in maintaining and activating the NPC populations of the OE. Our strategy to identify a 
gene of interest for maintaining NPC quiescence has turned up an otherwise overlooked 
candidate for further study.  
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